FDA approves Ionis ZANVASTRO as first disease-modifying treatment for Alexander disease
The FDA has approved Ionis Pharmaceuticals’ ZANVASTRO for pediatric and adult Alexander disease after a 54-patient study showed significant stabilization of gait at 61 weeks.